Townsquare Capital LLC Castle Biosciences Inc Transaction History
Townsquare Capital LLC
- $8.62 Billion
- Q4 2024
A detailed history of Townsquare Capital LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Townsquare Capital LLC holds 22,188 shares of CSTL stock, worth $428,006. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,188
Previous 23,270
4.65%
Holding current value
$428,006
Previous $663,000
10.86%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding CSTL
# of Institutions
210Shares Held
26.6MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$58.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$35.3 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$34.6 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$27.7 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$19.3 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $507M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...